Speakers

Book my booth

Accommodation

22-25 January 2018 // Hyatt Regency, Miami

Twitter

YouTube

Facebook

PURCHASE MY 2018 TICKET

Home

Conference Register for 2018 Download the Brochure Sign up for the optional sessions Speakers Agenda Personalized Event Planner Sample Attendee List Advisory Board Co-location with World Stem Cell Summit Venue & Accommodation

Download the Brochure

Speakers

Agenda

Personalized Event Planner

Sample Attendee List

Advisory Board

Co-location with World Stem Cell Summit

Venue & Accommodation

Features Phacilitate Training Course Investment Portal Japan Symposium Cord Blood & Perinatal Stem Cells Supply Chain & Logistics BioProcess Hub Translational Academy Yacht party Immuno-Oncology Hub I-O Collaboration Lunch Automation Report

Phacilitate Training Course

Investment Portal

Japan Symposium

Cord Blood & Perinatal Stem Cells

Supply Chain & Logistics

BioProcess Hub

Translational Academy

Yacht party

Immuno-Oncology Hub

I-O Collaboration Lunch

Automation Report

Sponsors & Exhibitors Become a Sponsor / Exhibitor

Become a Sponsor / Exhibitor

Resources All Content Nominate your top cell and gene therapy story of 2017 Manufacturing Supply Chain Market Access Investment The Phacilitate Blog

All Content

Nominate your top cell and gene therapy story of 2017

Manufacturing

Supply Chain

Market Access

Investment

The Phacilitate Blog

Why Phacilitate Meet the Team Contact us Testimonials Upcoming events

Meet the Team

Testimonials

Upcoming events

Registration

Immuno-Oncology Frontiers World

Phaciliatate - People/Speaker Categories Speaker (195) This field is required.

Speaker (195) This field is required.

All

Larry A. Couture Chief Executive Officer , Orbsen Therapeutics, Ltd

Mark A. Kay Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Vice Chair for Basic Research (Pediatrics) , Stanford University

Dr Adeyemi Afuwape Senior Consultant Regulatory Affairs - Cell and Gene Therapy , ERA Consulting (UK) Ltd

Dr Luca Alberici Chief Business Officer , MolMed

Dr Evren Alici CEO; Director, Cell & Gene Therapy Centre , Vycellix; Karolinska Institutet

Biren Amin Managing Director & Senior Equity Research Analyst, Biotechnology , Jefferies LLC

Jane C. Andrews, PhD Senior Director, Strategic Marketing , BioBridge Global

Philip Astley-Sparke Executive Chairman , Replimmune

Stefano Baila, PhD Director of Operations , Holding F.I.S.

Dr Christopher Ballas Senior Director, Process Development , WuXi AppTec

Dr Hiroto Bando Senior Director in the Regenerative Medicine Unit & Global Head of Cell Manufacturing Strategy , Takeda Pharmaceutical Company Ltd

Jakub Baran CEO & COO , Famicord Group, Polski Bank Komórek Macierzystych S.A.

Priya R. Baraniak, PhD Director of Business Development and Strategic Marketing , RoosterBio Inc.

Dr Oliver Bartelsen Global Head of Business Development and Industrial Sciences , Miltenyi Biotec

Shirley Bartido Director, Regulatory Affairs , Cellectis

Dr Nina Bauer Commercial Development, Autologous Therapies , Lonza, Inc

Dr John Beadle CEO , PsiOxus

Andrew Beavis Director of Analytical R&D , Celgene Corp, Cell Therapy Development

Dr Joanne Bedwell-Garner Development Director , Macrophage Pharma

Dr Reni Benjamin Senior Biotechnology Analyst , Raymond James & Associates, Inc

Kapil Bharti Stadtman Investigator, Unit on Ocular Stem Cell & Translational Research (OSCTR) , National Eye Institute, NIH

Greg Bonfiglio Founder & Managing Partner , Proteus, LLC

Debra K. Bowes Executive Vice President, Business and Strategic Development , MaxCyte

Dr Christopher Bravery Director , Advanced Biologicals Ltd

Steven Breazzano, PhD Equity Research Analyst , Evercore ISI

Mr Lee Buckler President & CEO , RepliCel Life Sciences Inc.

Dr Gunther Busam Head Procurement, Cell & Gene Therapies and Biologics Development , Novartis Pharma AG

Jon C. Gunther Associate Director, Technical R&D , Juno Therapeutics

Natika J. Calhoun, MS, ASQ-CQA, CTBS Director, Quality Assurance, Viral and Gene Therapy , MilliporeSigma

Catherine Cancian Vice President, Pharmaceutical Operations , GenSight Biologics

Arnold Caplan, PhD Director, Skeletal Research Center , Case Western Reserve University

Dr Stephen Cary CEO , Omniox

Massimiliano Cesarini Global Sales Manager , Comecer Group

Kyle J. Cetrulo Co-Founder & CEO , Auxocell Laboratories, Inc

Kenny Choi Head of Process Development & Tech Transfer , Mustang Bio

Laura Connelly-Smith, MBBCh,DM Assistant Medical Director Apheresis and Cellular Therapy / Assistant Professor, Division of Hematology / Assistant Member, FHCRC , SCCA / UW / Seattle Cancer Care Alliance

Albert Cooksey Vice President of Business Development , ICS, an AmerisourceBergen company

David Courtman Director, Biotherapeutics Core Facilities , Ottawa Hospital Research Institute

Abla A. Creasey, PhD Senior Director, Strategic Clinical, Regulatory & Infrastructure , California Institute for Regenerative Medicine (CIRM)

Dr Eva Dahlén Senior Director, Business Development , Alligator Bioscience

Sybil Danby Director of Business Development , Paragon Bioservices, Inc

Olivier Danos Chief Scientific Officer , REGENXBIO Inc.

Dr Anthony Davies President , Dark Horse Consulting

Dr John E. Davies Professor; President , University of Toronto; Tissue Regeneration Therapeutics, Inc

Gisèle Deblandre Project Management and Scientific Director , MaSTherCell

Dr Colleen Delaney Founder and Chief Medical Officer , Nohla Therapeutics

Jerrod Denham Principal & Senior Consultant , Dark Horse Consulting, Inc

Dr David DiGiusto Executive Director , Stanford University School of Medicine

Dr Boro Dropulic Chief Scientific Officer & General Manager , Lentigen Technology, Inc A Miltenyi Company

Dr Steven Dublin Global Product Manager , Miltenyi Biotec

Get my 2018 Ticket

Tweets by @Phacilitate

"The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy." Anne-Virginie Eggimann, Vice President, Regulatory Science, Bluebird Bio, Inc

“Great program, great people, great venue.” Klaus Kühlcke Managing Director, EUFETS GmbH

Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.” Nathalie Clement Associate Director, Powell Gene Therapy Center, University of Florida

"Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field." Dr James Trager Vice President, Research & Product Development, Dendreon

"It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives." Kurt Gielen Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.

“Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.” Steven Goodman Director, Strategy and Engagement, GSK

Book your booth

January 22nd, 2018: 16:30 - 19:30

January 23rd, 2018: 07:30 - 17:30

January 24th, 2018: 07:15 - 17:30

January 25th, 2018 : 07:30 - 17:30

View the agenda

Sales enquiries Call +44(0)207 384 8027 or peter.harkness@cellandgenetherapyworld.com

Delegate enquiries Call +44(0)207 384 7993 or kim@cellandgenetherapyworld.com

PRIVACY

T&Cs